Clinigen healthcare - how we work
Clinigen Healthcare is a Specialty Pharmaceutical company focused on acquiring its own intellectual property. We are seeking to acquire and in-license specialist, hospital only medicines worldwide. We will increase their value through developing new formulations and indications, registering in new territories and successfully commercializing within niche markets.
- Clinigen Healthcare has the knowledge and experience to take on global marketing authorizations and manufacturing commitments
- We can help companies undertake divestment, market withdrawal or rationalization strategies but maintain niche patient population access to products and maintain positive Key Opinion Leader relations
- We can enable pharmaceutical companies to realize value and focus resource on core growth assets
- We have the capability to maximize the value of assets within both licensed and unlicensed markets
- Our global network of partners ensures that, no matter where, the right drug gets to the right patient at the right time
Clinigen Healthcare is therefore a unique divestment partner for pharmaceutical companies who realize they may not be maximizing the value of their more problematic, unloved assets.
We have a wealth of knowledge and proven expertise in the following therapeutic areas:
Oncology |
Hematology |
Leukemia |
Transplantation |
Antivirals |
Pain management |
Critical care |
Orphan disease |
Clinigen’s first acquisition was Foscavir® from AstraZeneca in March 2010